{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:43:52Z","timestamp":1792489432349,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.kint.2026.07.022","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:29:57Z","timestamp":1792488597000},"page":"1102-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microvascular inflammation in kidney transplants: finally an effective treatment?"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7181-4664","authenticated-orcid":false,"given":"Mark","family":"Haas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes B.","family":"Fogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.07.022_bib1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ajt.2026.01.018","article-title":"The Banff 2024 meeting report: rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning","volume":"26","author":"Naesens","year":"2026","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2026.07.022_bib2","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ajt.2025.03.031","article-title":"Microvascular inflammation in kidney allografts: new directions for patient management","volume":"25","author":"Bohmig","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2026.07.022_bib3","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1681\/ASN.2020111558","article-title":"Missing self-induced microvascular rejection of kidney allografts: a population-based study","volume":"32","author":"Callemeyn","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.07.022_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2215\/CJN.00570122","article-title":"Association of HLA mismatches and histology suggestive of antibody-mediated injury in the absence of donor-specific anti-HLA antibodies","volume":"17","author":"Senev","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.07.022_bib5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular inflammation of kidney allografts and clinical outcomes","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.07.022_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1152\/physrev.00035.2007","article-title":"Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology","volume":"88","author":"Malavasi","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.kint.2026.07.022_bib7","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.kint.2026.06.033","article-title":"A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation","volume":"110","author":"Drasch","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.07.022_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65153-9","article-title":"Continuous indices to assess the phenotypic spectrum of kidney transplant rejection","volume":"16","author":"Vaulet","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2026.07.022_bib9","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.ekir.2025.07.009","article-title":"Anti-CD38 daratumumab treatment of chronic active antibody-mediated rejection","volume":"10","author":"Lye","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2026.07.022_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2026.07.022_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1868642","article-title":"Highly sensitized kidney transplant candidates: integrating acceptable mismatch, desensitization, imlifidase, and emerging immune-cell targeting strategies","volume":"17","author":"Reuter","year":"2026","journal-title":"Front Immunol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826007064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826007064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:34:00Z","timestamp":1792488840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826007064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0085253826007064"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.07.022","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microvascular inflammation in kidney transplants: finally an effective treatment?","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.06.033","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}